e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Biomarkers, diagnosis and outcome of respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia
J. Ben Halima, W. Ben Ahmed, L. El Gharbi, B. Dhari, S. Azzabi, M. A. Baccar, H. Aouina, H. Bouacha (Tunis, Tunisia)
Source:
Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Session:
Biomarkers, diagnosis and outcome of respiratory infections
Session type:
Thematic Poster Session
Number:
2704
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Ben Halima, W. Ben Ahmed, L. El Gharbi, B. Dhari, S. Azzabi, M. A. Baccar, H. Aouina, H. Bouacha (Tunis, Tunisia). Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Eur Respir J 2013; 42: Suppl. 57, 2704
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia
Source: Eur Respir J 2008; 31: 356-362
Year: 2008
Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Procalcitonin as etiological marker of severe community-acquired pneumonia
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Modern etiology of severe community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Relation between bacteremia and septic shock in patients with pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Impact of diabetes mellitus on inflammatory markers and severity scales in community-acquired pneumonia
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
Biomarkers and severity in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012
Physical deterioration during hospitalization in patients with community-acquired pneumonia
Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions
Year: 2015
Can procalcitonin or C-reactive protein predict supporative lung complications and ARDS at severe community-acquired pneumonia (CAP)?
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Influence of comorbidities on pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Community-acquired pneumonia with severe sepsis: Etiology and prognosis
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Clinical impact of a prediction score for drug-resistance in community-onset pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia
Source: Eur Respir J 2008; 32: 726-732
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept